RhumbLine Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $630M | Sell |
2,897,983
-65,138
| -2% | -$14.4M | 0.54% | 22 |
|
|
2025
Q4 | $677M | Sell |
2,963,121
-76,086
| -3% | -$17.3M | 0.55% | 21 |
|
|
2025
Q3 | $704M | Sell |
3,039,207
-30,676
| -1% | -$6.25M | 0.57% | 23 |
|
|
2025
Q2 | $570M | Buy |
3,069,883
+59,193
| +2% | +$11M | 0.49% | 24 |
|
|
2025
Q1 | $631M | Sell |
3,010,690
-26,376
| -0.9% | -$5.13M | 0.59% | 23 |
|
|
2024
Q4 | $540M | Sell |
3,037,066
-49,207
| -2% | -$9.05M | 0.48% | 25 |
|
|
2024
Q3 | $609M | Sell |
3,086,273
-75,888
| -2% | -$14.2M | 0.55% | 22 |
|
|
2024
Q2 | $542M | Sell |
3,162,161
-93,350
| -3% | -$15.5M | 0.51% | 23 |
|
|
2024
Q1 | $593M | Sell |
3,255,511
-27,308
| -0.8% | -$4.71M | 0.57% | 21 |
|
|
2023
Q4 | $509M | Buy |
3,282,819
+16,469
| +0.5% | +$2.4M | 0.53% | 22 |
|
|
2023
Q3 | $487M | Buy |
3,266,350
+23,250
| +0.7% | +$3.41M | 0.57% | 22 |
|
|
2023
Q2 | $437M | Buy |
3,243,100
+73,451
| +2% | +$10.8M | 0.49% | 26 |
|
|
2023
Q1 | $505M | Buy |
3,169,649
+170,080
| +6% | +$26M | 0.62% | 22 |
|
|
2022
Q4 | $485M | Buy |
2,999,569
+116,421
| +4% | +$17.9M | 0.65% | 23 |
|
|
2022
Q3 | $387M | Buy |
2,883,148
+98,281
| +4% | +$14.1M | 0.58% | 25 |
|
|
2022
Q2 | $427M | Buy |
2,784,867
+100,697
| +4% | +$15.4M | 0.62% | 22 |
|
|
2022
Q1 | $435M | Buy |
2,684,170
+16,348
| +0.6% | +$2.37M | 0.56% | 23 |
|
|
2021
Q4 | $361M | Buy |
2,667,822
+37,662
| +1% | +$4.45M | 0.44% | 37 |
|
|
2021
Q3 | $284M | Sell |
2,630,160
-51,334
| -2% | -$5.87M | 0.38% | 45 |
|
|
2021
Q2 | $302M | Sell |
2,681,494
-151,918
| -5% | -$17.1M | 0.4% | 45 |
|
|
2021
Q1 | $307M | Sell |
2,833,412
-160,379
| -5% | -$17.2M | 0.42% | 40 |
|
|
2020
Q4 | $321M | Sell |
2,993,791
-53,584
| -2% | -$5.15M | 0.44% | 37 |
|
|
2020
Q3 | $267M | Buy |
3,047,375
+27,064
| +0.9% | +$2.55M | 0.42% | 41 |
|
|
2020
Q2 | $297M | Buy |
3,020,311
+700,976
| +30% | +$61.7M | 0.5% | 35 |
|
|
2020
Q1 | $177M | Buy |
2,319,335
+4,637
| +0.2% | +$395K | 0.37% | 51 |
|
|
2019
Q4 | $205M | Sell |
2,314,698
-29,539
| -1% | -$2.45M | 0.34% | 55 |
|
|
2019
Q3 | $178M | Buy |
2,344,237
+23,679
| +1% | +$1.62M | 0.32% | 57 |
|
|
2019
Q2 | $169M | Sell |
2,320,558
-73,248
| -3% | -$5.76M | 0.32% | 57 |
|
|
2019
Q1 | $193M | Buy |
2,393,806
+82,463
| +4% | +$6.75M | 0.37% | 52 |
|
|
2018
Q4 | $213M | Sell |
2,311,343
-9,131
| -0.4% | -$803K | 0.46% | 37 |
|
|
2018
Q3 | $219M | Sell |
2,320,474
-92,562
| -4% | -$8.78M | 0.42% | 43 |
|
|
2018
Q2 | $224M | Sell |
2,413,036
-35,356
| -1% | -$3.45M | 0.45% | 38 |
|
|
2018
Q1 | $232M | Sell |
2,448,392
-54,752
| -2% | -$6.01M | 0.48% | 38 |
|
|
2017
Q4 | $242M | Buy |
2,503,144
+58,509
| +2% | +$5.51M | 0.49% | 39 |
|
|
2017
Q3 | $217M | Sell |
2,444,635
-14,766
| -0.6% | -$1.12M | 0.47% | 39 |
|
|
2017
Q2 | $178M | Buy |
2,459,401
+4,087
| +0.2% | +$275K | 0.41% | 40 |
|
|
2017
Q1 | $160M | Buy |
2,455,314
+7,181
| +0.3% | +$451K | 0.37% | 42 |
|
|
2016
Q4 | $153M | Buy |
2,448,133
+53,561
| +2% | +$3.27M | 0.39% | 43 |
|
|
2016
Q3 | $151M | Buy |
2,394,572
+113,209
| +5% | +$7.33M | 0.42% | 44 |
|
|
2016
Q2 | $141M | Buy |
2,281,363
+81,773
| +4% | +$4.98M | 0.42% | 43 |
|
|
2016
Q1 | $126M | Buy |
2,199,590
+71,052
| +3% | +$3.96M | 0.39% | 46 |
|
|
2015
Q4 | $126M | Sell |
2,128,538
-270,650
| -11% | -$15.6M | 0.41% | 47 |
|
|
2015
Q3 | $131M | Sell |
2,399,188
-26,132
| -1% | -$1.7M | 0.44% | 39 |
|
|
2015
Q2 | $163M | Sell |
2,425,320
-250,511
| -9% | -$16.4M | 0.52% | 34 |
|
|
2015
Q1 | $157M | Sell |
2,675,831
-13,854
| -0.5% | -$837K | 0.45% | 46 |
|
|
2014
Q4 | $176M | Sell |
2,689,685
-65,884
| -2% | -$4.15M | 0.51% | 38 |
|
|
2014
Q3 | $159M | Sell |
2,755,569
-38,396
| -1% | -$2.13M | 0.48% | 39 |
|
|
2014
Q2 | $158M | Sell |
2,793,965
-66,161
| -2% | -$3.47M | 0.46% | 40 |
|
|
2014
Q1 | $147M | Sell |
2,860,126
-19,348
| -0.7% | -$978K | 0.44% | 45 |
|
|
2013
Q4 | $152M | Sell |
2,879,474
-125,589
| -4% | -$6.17M | 0.45% | 42 |
|
|
2013
Q3 | $134M | Buy |
3,005,063
+20,613
| +0.7% | +$914K | 0.42% | 44 |
|
|
2013
Q2 | $123M | Buy |
+2,984,450
| New | +$131M | 0.4% | 46 |
|
Other funds holding ABBV
VCM
VPM
RhumbLine Advisers's ABBV Position: Q1 2026 in Review
RhumbLine Advisers reduced its AbbVie (ABBV) stake by 2.2% in Q1 2026, selling an estimated $14.4M and leaving 2,897,983 shares worth $630M. The position accounts for 0.54% of the portfolio, ranked #22.
RhumbLine Advisers first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $704M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- RhumbLine Advisers held 2,897,983 shares of AbbVie worth $630M as of Q1 2026.
- RhumbLine Advisers sold 65,138 AbbVie shares in Q1 2026, an estimated $14.4M.
- AbbVie made up 0.54% of RhumbLine Advisers's portfolio in Q1 2026, its #22 holding.
- RhumbLine Advisers first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's AbbVie position peaked at $704M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.